Featured Research

from universities, journals, and other organizations

Drug Shows Promise In Preventing Type 1 Diabetes

Date:
April 30, 2003
Source:
University Of Virginia Health System
Summary:
An anti-inflammatory drug called lisofylline, originally developed as an infection-fighter for cancer patients, could be beneficial for people at risk for Type 1 diabetes, according to researchers at the University of Virginia Health System.

CHARLOTTESVILLE, Va., April 30 – An anti-inflammatory drug called lisofylline, originally developed as an infection-fighter for cancer patients, could be beneficial for people at risk for Type 1 diabetes, according to researchers at the University of Virginia Health System.

U.Va. researchers discovered that two weeks of lisofylline (LSF) treatment reduced the incidence of Type 1 diabetes in mice to 25 percent compared to 92 percent in mice who did not receive LSF. Diabetes was induced in the mice by multiple low doses of a certain drug.

Type 1 diabetes, also known as insulin dependent diabetes mellitus, occurs when the immune system attacks beta cells in the pancreas, leaving the body unable to produce insulin. Insulin is needed by the body to process sugar, the basic fuel for cells.

"Our hope is that, one day, a clinician can use lisofylline to slow down or prevent this disease in people at high-risk for Type 1 diabetes," said Dr. Zandong Yang, an assistant professor of research in the division of endocrinology and metabolism at U.Va. "We think this drug may have the ability to protect these insulin-producing cells from death or damage. "

The research by Dr. Yang's team is published in the April 30 online issue of the journal Pancreas, found on the web at: http://www.pancreasjournal.com.

The U.Va. researchers say lisofylline protects insulin-producing cells by inhibiting the production and action of pro-inflammatory cytokines, proteins produced by immune cells that can cause cell death and dysfunction. Importantly, LSF treatment also restored insulin secretion, according to the U.Va. study.

More than 700,000 Americans suffer from Type 1 diabetes, according to the American Diabetes Association (ADA.) Most require several insulin injections a day or an insulin pump. Type 1 diabetes accounts for about five to 10 percent of all diagnosed cases of diabetes, according to the ADA. People with Type 1 diabetes are at a greater risk for heart disease, stroke, and eye and kidney diseases. Causes of Type 1 are believed to include autoimmune, genetic and environmental factors.


Story Source:

The above story is based on materials provided by University Of Virginia Health System. Note: Materials may be edited for content and length.


Cite This Page:

University Of Virginia Health System. "Drug Shows Promise In Preventing Type 1 Diabetes." ScienceDaily. ScienceDaily, 30 April 2003. <www.sciencedaily.com/releases/2003/04/030430081525.htm>.
University Of Virginia Health System. (2003, April 30). Drug Shows Promise In Preventing Type 1 Diabetes. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2003/04/030430081525.htm
University Of Virginia Health System. "Drug Shows Promise In Preventing Type 1 Diabetes." ScienceDaily. www.sciencedaily.com/releases/2003/04/030430081525.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins